Literature DB >> 4089530

Serum ferritin and Hodgkin's disease.

W R Bezwoda, D P Derman, T H Bothwell, R Baynes, C Hesdorffer, A P MacPhail.   

Abstract

The haemoglobin, serum iron, transferrin saturation, serum ferritin, erythrocyte sedimentation rate (ESR), splenic weight and non-haem iron concentration in the marrow, liver and spleen were measured prior to treatment in 35 patients with Hodgkin's disease who underwent staging laparatomy. The Hb, serum iron and transferrin saturation showed a significant decrease with increasing stage of the disease. In contrast, there was a significant increase in the serum ferritin, ESR, splenic weight and in all the tissue non-haem iron concentrations. The calculated total iron content of the body remained relatively constant throughout at about 2 g but with increasing stage there was an internal redistribution of iron, with a progressive drop in Hb iron and a reciprocal rise in storage iron, especially in the liver. Serum ferritin concentrations, which rose with progression of the disease, were inappropriately high in relation to the size of body stores at all stages but especially in patients with 4B disease and hepatic involvement. It was concluded that the serum ferritin concentrations are raised for several reasons in Hodgkin's disease. They reflect an increase in body iron stores, ferritin's role as an 'acute phase' protein in the inflammatory response and hepatic damage in patients with advanced disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4089530     DOI: 10.1111/j.1600-0609.1985.tb02820.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  4 in total

1.  On the prediction of Hodgkin lymphoma treatment response.

Authors:  E J deAndrés-Galiana; J L Fernández-Martínez; O Luaces; J J Del Coz; R Fernández; J Solano; E A Nogués; Y Zanabilli; J M Alonso; A R Payer; J M Vicente; J Medina; F Taboada; M Vargas; C Alarcón; M Morán; A González-Ordóñez; M A Palicio; S Ortiz; C Chamorro; S Gonzalez; A P González-Rodríguez
Journal:  Clin Transl Oncol       Date:  2015-04-21       Impact factor: 3.405

2.  Detecting iron deficiency in anemic patients with concomitant medical problems.

Authors:  A M Kis; M Carnes
Journal:  J Gen Intern Med       Date:  1998-07       Impact factor: 5.128

3.  Placental isoferritin (PLF) in comparison with MCA and CEA in advanced breast cancer--first data from a pilot study.

Authors:  M Stierer; H R Rosen; E Forster; C Moroz
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

4.  Iron metabolism and fungal infections in patients with haematological malignancies.

Authors:  C Iglesias-Osma; L Gonzalez-Villaron; J F San Miguel; M D Caballero; L Vazquez; S de Castro
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.